Appendix B: Drug Characteristics Tables
Characteristics of Protease Inhibitors
Appendix B, Table 5. Characteristics of Protease Inhibitors
The older protease inhibitors (PIs) fosamprenavir (FPV), indinavir (IDV), nelfinavir (NFV), saquinavir (SQV), and tipranavir (TPV) are no longer used commonly in clinical practice and have been removed from this table. Please refer to the July 10, 2019 version of the guidelines (found in the archived guidelines section of Clinicalinfo) or to the Food and Drug Administration product labels for information regarding these drugs.
| Appendix B, Table 5. Characteristics of Protease Inhibitorsa | |
|---|---|
Appendix B: Drug Characteristics Tables
Characteristics of Protease Inhibitors
Appendix B, Table 5. Characteristics of Protease Inhibitors
The older protease inhibitors (PIs) fosamprenavir (FPV), indinavir (IDV), nelfinavir (NFV), saquinavir (SQV), and tipranavir (TPV) are no longer used commonly in clinical practice and have been removed from this table. Please refer to the July 10, 2019 version of the guidelines (found in the archived guidelines section of Clinicalinfo) or to the Food and Drug Administration product labels for information regarding these drugs.
| Appendix B, Table 5. Characteristics of Protease Inhibitorsa | |
|---|---|
Download Guidelines
- Section OnlyPDF (319.88 KB)
- Full GuidelinePDF (2.44 MB)
- Recommendations OnlyPDF (229.24 KB)
- Tables OnlyPDF (939.48 KB)